Aroa Biosurgery Limited is a New Zealand-based regenerative medicine company. The Company develops, manufactures and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction using its extracellular matrix (ECM) technology. Its AROA ECM is a platform technology, containing biomaterial complex mix of biological molecules that is building block for range of soft tissue repair products. Its products include Endoform Antimicrobial Restorative Bioscaffold, Endoform Natural Restorative Bioscaffold, Myriad Matrix, Myriad Morcells and Reinforced Bioscaffolds. Its Endoform Antimicrobial Restorative Bioscaffold and Endoform Natural Restorative Bioscaffold are ECM products for the management of acute and chronic wounds. Its Myriad Matrix is used for soft tissue repair, reinforcement and complex wounds, specifically designed to maximize tissue repair while providing versatility and adaptability across a range of surgical applications.